|
| n | Overall survival (95% CI) | p-value |
| Whole study cohort | 39 | 12.5 (8.7 - 16.3) |
|
| Tumor load of the liver: |
|
|
|
| 1% - 20% | 18 | 13.4 (6.3 - 20.5) |
|
| >20% | 21 | 10.8 (8.0 - 13.5) | 0.248 |
| Number of tumors: |
|
|
|
| 1 ? 5 | 15 | 16.7 (7.1 - 26.3) |
|
| > 5 | 24 | 10.8 (7.8 - 13.7 | 0.151 |
| Visual vascularisation score |
|
|
|
| MRI |
|
|
|
| Low | 8 | 12.1 (5.2 - 19.0) | - |
| Medium | 13 | 10.8 (2.8 - 18.7) | 0.698 |
| High | 18 | 12.5 (0.5 - 24.5) | 0.511 |
| Scintigraphy |
|
|
|
| Low | 9 | 12.1 (0 - 28.4) | - |
| Medium | 15 | 9.1 (6.1 - 12.1) | 0.749 |
| High | 15 | 17.4 (7.7 - 27.1) | 0.196 |
| Angiography |
|
|
|
| Low | 14 | 13.4 (2.3 - 24.5) | - |
| Medium | 14 | 9.8 (7.8 ? 11.8) | 0.963 |
| High | 11 | 12.5 (3.0 - 22.0) | 0.415 |
| Combination of all modalities |
|
|
|
| Low | 8 | 3.8 (0-15.0) | - |
| Medium | 19 | 10.8 (0 - 22.1) | 0.043 |
| High | 12 | 12.5 (7.4 - 17.6) | 0.090 |